LRP6 and early-onset autosomal dominant Alzheimer disease: In addition, it was also shown that an isoform that skips the third exon of LRP6 and displays reduced Wnt/β-catenin signaling activation is significantly augmented in the brains of patients with Alzheimer’s disease (Alarcón et al., 2013).